Question:
Which of the following drug is NOT used in treatment of H. Pylori infection
Which of the following drug is NOT used in treatment of H. Pylori infection
Updated On: Apr 28, 2025
- Ampicillin
- Clarithromycin
- Mosapride
- Bismuth
Hide Solution
Verified By Collegedunia
The Correct Option is C
Solution and Explanation
The correct option is (C): Mosapride
Was this answer helpful?
0
0
Top Questions on Applied drug information
- The short-acting anticholinesterase drug is:
- GPAT - 2024
- Clinical Pharmacy and Therapeutics
- Applied drug information
- Which among the following is not the process of drug degradation:
- GPAT - 2024
- Clinical Pharmacy and Therapeutics
- Applied drug information
- Which among the following is not the process of drug degradation:
- GPAT - 2024
- Clinical Pharmacy and Therapeutics
- Applied drug information
- The short acting anticholinesterase drug is:
- GPAT - 2024
- Clinical Pharmacy and Therapeutics
- Applied drug information
- Which of the following formulations are “pharma- ceutically equivalent"? Match the List-I with List-IIChoose the correct answer from the options given below:
Ingrediant Function Table A Table B Table C Table D A Aceta- minophen I Drug 300 mg - 300 mg 300 mg B Aspirin II Drug - 300 mg - - C Lactose III Filler 100 mg 100 mg - 100 mg D Avicel IV Filler - - 100 mg - starch Dis-integrant 50 mg 50 mg - 50 mg Avicel Dis-integrant - - 50 mg - Magsterate Lubricant 2 mg 2 mg 2 mg 2 mg Gelatin Binder 10 mg 10 mg 10 mg 10 mg - GPAT - 2023
- Pharmaceutics
- Applied drug information
View More Questions
Questions Asked in GPAT exam
- Match the following:
(P) Schedule H
(Q) Schedule G
(R) Schedule P
(S) Schedule F2
Descriptions:
(I) Life period of drugs
(II) Drugs used under RMP
(III) List of Prescription Drugs
(IV) Standards for surgical dressing- GPAT - 2025
- Drug therapy
- Minimum manufacturing space for 'Habb-Unani medicine' as per Schedule of D and C Act?
- GPAT - 2025
- Pharma Techniques
- If the label or the container bears the name of an individual or company purporting to be the manufacturer of the drug, which individual or company is fictitious or does not exist, it is:
- GPAT - 2025
- Drug therapy
- Match the following:
(1) Schedule FF
(2) Schedule F3
(3) Schedule V
(4) Schedule Y
Descriptions:
(P) Standards of patent and proprietary medicines
(Q) Requirements and guidelines for clinical trials
(R) Standards for sterilized umbilical tapes
(S) Standards for Ophthalmic preparations- GPAT - 2025
- Drug therapy
Match the following Class and their Drug:
(1) Alkylating (P) 5-fluorouracil
(2) Platinum analog (Q) Cisplatin
(3) Antimetabolite (R) Cetuximab
(4) EGF receptor inhibitor (S) Chlorambucil- GPAT - 2025
- Biostatistics and Research Methodology
View More Questions